Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT06717659
Recruiting Not applicable

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Fu Jen Catholic University
Phase
Not applicable
Started
2024-12-05
Last updated
2026-02-27

Condition(s) studied

COPD (Chronic Obstructive Pulmonary Disease)Probiotic InterventionBody Composition Measurement

Investigational drug(s) / intervention(s)

probiotic supplementation interventionstandard pulmonnary rehabilitation

probiotic supplementation intervention: probiotic supplementation will be administered, while participants continue undergoing routine pulmonary rehabilitation therapy

standard pulmonnary rehabilitation: undergo routine pulmonary rehabilitation without probiotics intervention

Study summary

This study aims to investigate various aspects of patients with chronic respiratory diseases undergoing pulmonary rehabilitation supplemented with probiotics. The focus will be on clinical physiological responses, functional performance, respiratory status assessments, nutritional status evaluations, body composition analyses, and biochemical blood parameters, with a primary emphasis on the anti-inflammatory response.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Willing to sign a written informed consent form. * Diagnosed with pre-COPD or COPD stage I-IV according to the 2023 GOLD guidelines. * Undergoing pulmonary rehabilitation therapy for more than three months. Exclusion Criteria: * Under 18 years old. * Diagnosed with neuromuscular diseases. * Experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months. * Unable to cooperate with cardiopulmonary exercise testing. * Has other diseases or behavioral restrictions preventing participation in exercise training for over one year. * Assessed by a physician to have severe malnutrition or a significantly low BMI.

Primary outcome measure(s)

  • interleukin-6 — six weeks
    inflammation evaluation

Trial sites (1)

FacilityCityRegionStatus
Fu Jen Catholic University Hospital, Fu Jen Catholic University New Taipei City Taiwan Recruiting

More Fu Jen Catholic University trials in Taiwan

Regional Innovation in Chronic Disease and Elderly Care Recruiting
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients Recruiting
Pressure-Sensing Mattresses and Mechanical Ventilation Weaning in Neonatal Recruiting
Association Between Cardiopulmonary Function and Plantar Pressure in Patients With Chronic Obstructive Pulmonary Disease Recruiting
Development of a Multimodal Deep Learning Model for Pediatric Patients Recruiting

Other trials for the same condition

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Recruiting
Effectiveness of Active Cycle of Breathing Techniques in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06717659 on ClinicalTrials.gov ↗ ← All trials in Taiwan